Page 4 - Standard Deviation News Today

A new analysis of Google search results provides perspective into the readability and quality of educational materials available online related to iron deficiency anemia.

Abscissa - the horizontal baseline of a chart, x-axis.

Mutual Fund Report for KTCAX

Viet Le, DMSc, PA-C, discusses early data from the Target-D trial and how this might influence the way he interprets the findings from other vitamin D supplementation studies.

Results of the ARTESIA trial suggest apixaban lowered stroke risk by 37% in subclinical atrial fibrillation versus aspirin, but increased major bleeding risk.

Presented at AHA 2023, phase 1 data for lepodisiran showcased a 97% reduction in lipoprotein(a) levels at the 608 mg dose.

Full data from the SELECT trial offer insight into the 20% relative risk reduction associated with use of semaglutide 2.4 mg in patients with overweight or obesity and preexisting cardiovascular disease at AHA 2023.

The MINT trial, which included 3504 patients with acute MI and anemia, shows a trend favoring liberal transfusion, indicating a potential for improved outcomes.

Golds returns are neary two-fold in comparison to Nifty and Sensex which have delivered returns of 10.34% and 9.31%, respectively, since last Dhanteras which fell on October 22, 2022.

On November 7, 2023, Record Medcial announced the FDA approval of their Paradise Ultrasound Renal Denervation system for the treatment of hypertension.